₩38,400.00 ($28.59)

-1250.00 (-3.15%)

Weekly Expected Move ±3.4%

₩35808 ₩37104 ₩38400 ₩39696 ₩40992

KOE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · ₩1.70T mcap · 20M float · 0.477% daily turnover

Revenue

$536.4B +12.3% ▲

5Y CAGR: +18.1%

Gross Profit

$161.0B +31.9% ▲

5Y CAGR: +17.6%

Operating Income

$56.1B +50.7% ▲

5Y CAGR: +18.9%

Net Income

$38.8B +76.4% ▲

5Y CAGR: +13.1%

EPS (Diluted)

$891.88 +71.6% ▲

5Y CAGR: +13.2%

EBITDA

$78.4B +36.7% ▲

5Y CAGR: +15.5%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$398.7B	$386.0B	$388.8B	$477.8B	$536.4B
YoY Growth	+70.7%	-3.2%	+0.7%	+22.9%	+12.3%
Cost of Revenue	$280.5B	$274.4B	$269.1B	$355.8B	$375.4B
Gross Profit	$118.2B	$111.7B	$119.7B	$122.0B	$161.0B
Gross Margin	29.7%	28.9%	30.8%	25.5%	30.0%
R&D Expenses	$6.4B	$8.0B	$12.7B	$13.0B	$19.1B
SG&A Expenses	$34.2B	$34.5B	$35.2B	$31.9B	$85.8B
Operating Expenses	$70.5B	$73.5B	$83.6B	$84.8B	$104.9B
Operating Income	$47.8B	$38.2B	$36.1B	$37.2B	$56.1B
Operating Margin	12.0%	9.9%	9.3%	7.8%	10.5%
Interest Expense	$5.4B	$6.2B	$8.3B	$7.5B	$6.7B
Income Before Tax	$42.5B	$30.5B	$26.2B	$29.8B	$49.7B
Tax Expense	$7.9B	$4.5B	$4.9B	$7.8B	$11.0B
Net Income	$34.6B	$26.0B	$21.3B	$22.0B	$38.8B
Net Margin	8.7%	6.7%	5.5%	4.6%	7.2%
EPS (Diluted)	$791.28	$595.92	$488.57	$530.00	$891.88
EBITDA	$64.3B	$54.1B	$54.2B	$57.4B	$78.4B
Shares Outstanding	42M	42M	44M	43M	43M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$128.1B	$135.6B	$112.5B	$131.3B	$138.2B	$154.4B	$132.1B	$153.3B
Cost of Revenue	$94.0B	$101.2B	$79.1B	$90.5B	$95.6B	$110.2B	$94.3B	$104.2B
Gross Profit	$34.1B	$34.3B	$33.4B	$40.8B	$42.6B	$44.2B	$37.8B	$49.1B
Gross Margin	26.6%	25.3%	29.7%	31.1%	30.8%	28.6%	28.6%	32.0%
R&D Expenses	$2.6B	$4.5B	$3.1B	$2.9B	$4.2B	$8.9B	$3.7B	$0
SG&A Expenses	-$10.5B	$9.8B	$8.9B	$25.3B	$9.9B	$12.7B	$9.3B	$12.7B
Operating Expenses	$20.5B	$23.9B	$22.6B	$25.3B	$26.5B	$30.5B	$24.9B	$29.8B
Operating Income	$13.6B	$10.5B	$10.7B	$15.5B	$16.1B	$13.7B	$12.9B	$19.3B
Operating Margin	10.7%	7.7%	9.5%	11.8%	11.7%	8.9%	9.8%	12.6%
Interest Expense	$1.9B	$1.9B	$1.8B	$1.7B	$1.6B	$1.6B	$1.6B	$1.6B
Income Before Tax	$12.1B	$8.1B	$9.5B	$14.6B	$15.1B	$10.5B	$11.8B	$18.5B
Tax Expense	$3.8B	$1.9B	$2.2B	$3.5B	$3.7B	$1.6B	$3.0B	$4.8B
Net Income	$8.3B	$6.2B	$7.3B	$11.1B	$11.5B	$8.9B	$8.8B	$13.7B
Net Margin	6.5%	4.6%	6.5%	8.4%	8.3%	5.8%	6.7%	9.0%
EPS (Diluted)	$190.48	$142.77	$168.47	$255.04	$258.82	$204.43	$199.00	$310.00
EBITDA	$19.1B	$14.8B	$16.5B	$46.4B	$22.4B	$19.5B	$19.2B	$25.0B
Shares Outstanding	43M	43M	43M	43M	43M	43M	45M	45M

068760.KQ KOE